Error: Could not add to watchlist. X

Progenics Pharmaceuticals Inc

+ Watchlist
PGNX:US
NASDAQ GS
6.97
USD
0.12
1.69%
As of 20:10:00 ET on 07/03/2015.
Open
7.12
Day Range
6.92 - 7.36
Volume
1,260,998
Previous Close
7.09
52Wk Range
4.02 - 9.27
1 Yr Return
51.19%
Current P/E Ratio (TTM)
160.89
Earnings per Share (USD) (TTM)
0.04
Market Cap (m USD)
485.425
Shares Outstanding (m)
69.645
Price/Sales (TTM)
11.13
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
ADDRESS
777 Old Saw Mill River Road
Tarrytown, NY 10591
United States
PHONE
1-914-789-2800
  • Mark Robert Baker
    Chief Executive Officer
  • Vivien Wong
    Exec VP:Development
  • Robert J Israel
    Exec VP:Innovation
  • Nitya G Ray
    Senior VP:Manufacturing
  • Angelo W Lovallo
    VP:Finance/Treasurer
Show More